We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$9.62B
AUM Growth
+$482M
(+5.3%)
Cap. Flow
+$328M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
35.81%
Holding
1,132
New
163
Increased
147
Reduced
109
Closed
164
Avg Time Held Equity + Options
2.6
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.6
quarters
Avg Time Held Equity only
2.6
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$454M |
| 2 |
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$312M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$286M |
| 4 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$248M |
| 5 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$220M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$829M |
| 2 |
MIME
Mimecast Limited
MIME
|
+$351M |
| 3 |
PLAN
Anaplan, Inc.
PLAN
|
+$325M |
| 4 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$260M |
| 5 |
VNE
Veoneer, Inc.
VNE
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.77% |
| 2 | Financials | 20.95% |
| 3 | Industrials | 11.05% |
| 4 | Real Estate | 10.82% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Zentalis Pharmaceuticals
ZNTL
$227M
| $2.22M | 0.02% |
79,127
+61,625
| +352% | +$1.63M |
2022 Q1
1 quarter
|
|
602
UMH Properties
UMH
$1.3B
| $2.16M | 0.02% |
122,420
+2,937
| +2% | +$61K |
2021 Q4
2 quarters
|
|
603
Valero Energy
VLO
$131B
| $2.16M | 0.02% |
+20,306
| New | +$2.4M |
2022 Q2
0 quarters
|
|
604
Immunocore
IMCR
$1.43B
| $2.15M | 0.02% |
57,497
+19,497
| +51% | +$633K |
2022 Q1
1 quarter
|
|
605
QT Imaging Holdings
QTI
$35.9M
| $2.12M | 0.02% |
210,009
| – | – |
2021 Q4
2 quarters
|
|
|
GFX
606
DELISTED
Golden Falcon Acquisition Corp.
GFX
| $2.12M | 0.02% |
215,177
| – | – |
2021 Q1
5 quarters
|
|
607
DELISTED
CERo Therapeutics
CERO
| $2.11M | 0.02% |
105
| – | – |
2021 Q4
2 quarters
|
|
|
MTRY
608
DELISTED
Monterey Innovation Acquisition Corp. Common Stock
MTRY
| $2.1M | 0.02% |
210,009
| – | – |
2021 Q4
2 quarters
|
|
609
Tigo Energy
TYGO
$71.7M
| $2.1M | 0.02% |
210,009
| – | – |
2021 Q3
3 quarters
|
|
610
DELISTED
Lionheart III Corp Class A Common Stock
LION
| $2.1M | 0.02% |
210,009
| – | – |
2021 Q4
2 quarters
|
|
611
Syntec Optics
OPTX
$309M
| $2.1M | 0.02% |
210,009
| – | – |
2022 Q1
1 quarter
|
|
|
NGC
612
DELISTED
Northern Genesis Acquisition Corp. III
NGC
| $2.09M | 0.02% |
213,516
| – | – |
2021 Q2
4 quarters
|
|
613
CareTrust REIT
CTRE
$8.64B
| $2.08M | 0.02% |
112,817
-13,558
| -11% | -$240K |
2022 Q1
1 quarter
|
|
|
SWSS
614
DELISTED
Clean Energy Special Situations Corp. Common stock
SWSS
| $2.08M | 0.02% |
420,018
| – | – |
2021 Q4
2 quarters
|
|
615
Incyte
INCY
$22B
| $2.07M | 0.02% |
27,289
+14,959
| +121% | +$1.14M |
2022 Q1
1 quarter
|
|
616
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
| $2.07M | 0.02% |
205,900
| – | – |
2022 Q1
1 quarter
|
|
|
FRBN
617
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $2.06M | 0.02% |
+205,900
| New | +$2.05M |
2022 Q2
0 quarters
|
|
618
Ocular Therapeutix
OCUL
$1.59B
| $2.06M | 0.02% |
512,886
+212,886
| +71% | +$804K |
2022 Q1
1 quarter
|
|
619
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $2.05M | 0.02% |
205,900
| – | – |
2022 Q1
1 quarter
|
|
620
PUT
Royal Caribbean
RCL
$75.3B
| $2.05M | 0.02% |
54,200
+17,500
| +48% | +$1.09M |
2021 Q2
4 quarters
|
|
|
CPTK
621
DELISTED
Crown PropTech Acquisitions
CPTK
| $2.05M | 0.02% |
207,965
| – | – |
2021 Q2
4 quarters
|
|
622
Axalta
AXTA
$7.18B
| $2.04M | 0.02% |
92,070
-22,298
| -19% | -$567K |
2018 Q4
14 quarters
|
|
623
flyExclusive
FLYX
$65.2M
| $2.04M | 0.02% |
209,191
| – | – |
2021 Q3
3 quarters
|
|
|
JYAC
624
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $2.03M | 0.02% |
205,900
| – | – |
2022 Q1
1 quarter
|
|
625
ReNew
RNW
$2.51B
| $2.03M | 0.02% |
+313,452
| New | +$2.26M |
2022 Q2
0 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2022 Portfolio in Review
As of Q2 2022, UBS O'Connor held 1,132 positions worth $9.62B, up 5.3% from $9.14B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
UBS O'Connor deployed $328M of net new capital in Q2 2022, opening 163 new positions and adding to 147 existing holdings. Its largest new stake was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Occidental Petroleum Corp Warrants, an estimated $15.7M trimmed.
- UBS O'Connor's largest Q2 2022 buy was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
- UBS O'Connor added most to Mandiant, Inc. Common Stock in Q2 2022, an estimated $220M increase.
- UBS O'Connor's biggest Q2 2022 reduction was Occidental Petroleum Corp Warrants, cutting an estimated $15.7M.
- UBS O'Connor fully exited Cerner Corp in Q2 2022, selling an estimated $829M.
- UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
- UBS O'Connor opened 163 new positions and closed 164 in Q2 2022.
- UBS O'Connor's portfolio value rose 5.3% quarter-over-quarter to $9.62B.
Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.